These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32592893)

  • 1. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    Hsu YC; Luo CW; Huang WL; Wu CC; Chou CL; Chen CI; Chang SJ; Chai CY; Wang HC; Chen TY; Li CF; Pan MR
    Radiother Oncol; 2020 Aug; 149():249-258. PubMed ID: 32592893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
    J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH
    Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
    Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ
    Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
    Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.
    Lin CY; Sheu MJ; Li CF; Lee SW; Lin LC; Wang YF; Chen SH
    Tumour Biol; 2014 Jul; 35(7):6823-30. PubMed ID: 24729124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF
    Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
    J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
    Chen TJ; He HL; Shiue YL; Yang CC; Lin LC; Tian YF; Chen SH
    Int J Med Sci; 2018; 15(11):1171-1178. PubMed ID: 30123054
    [No Abstract]   [Full Text] [Related]  

  • 12. Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
    Sheu MJ; Chou CL; Yang CC; Lee SW; Tian YF; Lin CY; Hsiao SY; Chen SH; Huang WT
    Pathol Res Pract; 2020 May; 216(5):152922. PubMed ID: 32249003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like Factor 4 Modulates Development of BMI1(+) Intestinal Stem Cell-Derived Lineage Following γ-Radiation-Induced Gut Injury in Mice.
    Kuruvilla JG; Kim CK; Ghaleb AM; Bialkowska AB; Kuo CJ; Yang VW
    Stem Cell Reports; 2016 Jun; 6(6):815-824. PubMed ID: 27237377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer.
    Yu T; Chen X; Zhang W; Colon D; Shi J; Napier D; Rychahou P; Lu W; Lee EY; Weiss HL; Evers BM; Liu C
    J Biol Chem; 2012 Feb; 287(6):3760-8. PubMed ID: 22170051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
    J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
    Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
    Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT.
    Chen HP; Chen CI; Liu KW; Chen TJ; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Li CF; Chou CL; Lai HY
    Pathol Res Pract; 2022 Nov; 239():154158. PubMed ID: 36244249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
    Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
    Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
    Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative endoscopic tattooing technique improved lymph node retrieval in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    Chen YT; Wang JY; Wang JW; Chai CY
    J Clin Pathol; 2020 May; 73(5):267-272. PubMed ID: 31690565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.